Skip to main content
. Author manuscript; available in PMC: 2007 Aug 28.
Published in final edited form as: J Biol Chem. 2002 Aug 9;277(42):39327–39333. doi: 10.1074/jbc.M111841200

Fig. 5. Expression of VLA4 on the surface of MBP-primed T cells.

Fig. 5

Normal or MBP-primed T cells were treated with 0.5 ml of appropriately diluted FITC-labeled anti-VLA α4 for 30 min followed by FACS analysis. A, FITC-unconjugated normal T cells; B, FITC-conjugated normal T cells; C, FITC-conjugated MBP-primed T cells. In D, similarly MBP-primed T cells that were treated with 50 units/ml IFN-β during priming with 50 μg/ml MBP for 4 days were analyzed by FACS.